Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation

Orphanet journal of rare diseases

Volumn 9, Issue , 2014, Pages 162-

  Vantyghem, Marie Christine ^a   Cornillon, Jérôme ^a   Decanter, Christine ^a   Defrance, Frédérique ^a   Karrouz, Wassila ^a   Leroy, Clara ^a   Le Mapihan, Kristell ^a   Couturier, Marie Anne ^a   De Berranger, Eva ^a   Hermet, Eric ^a   Maillard, Natacha ^a   Marcais, Ambroise ^a   Francois, Sylvie ^a   Tabrizi, Reza ^a   Yakoub Agha, Ibrahim ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVERSE EFFECTS; DISEASE MANAGEMENT; ENDOCRINE SYSTEM DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE SUBSTITUTION; HUMAN; METABOLIC DISEASES; PROCEDURES; TRENDS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE MANAGEMENT; ENDOCRINE SYSTEM DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE REPLACEMENT THERAPY; HUMANS; METABOLIC DISEASES;

EID: 85003353037     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/s13023-014-0162-0     Document Type: Review

References (0)